Navigation Links
Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
Date:5/7/2008

in cancer patients.

Champions Biotechnology leverages its preclinical platform to evaluate drug candidates and to develop a portfolio of novel therapeutic candidates through pre-clinical trials. As drugs progress through this early stage of development, the Company plans to sell, partner or license them to pharmaceutical and/or biotechnology companies, as appropriate. The Company also offers its predictive preclinical platform and tumor specific data to physicians for personalized patient care. In the course of this process, this permits Champions Biotechnology to evaluate oncology drugs for companies by using models that integrate prognostic testing with biomarker discovery.

Champions Biotechnology is dedicated to enhancing preclinical development tools, accelerating development and valuation of oncology drugs, and advancing personalized treatment with a goal to improve the lives of cancer patients globally.

This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties. Champions Biotechnology generally uses words such as "believe," "may," "could," "will," "intend," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements. One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors. See Champions Biotechnology's Form 10-KSB for the fiscal year ended April 30, 2007 for a discussion of such risks, uncertainties and other factors. Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Biotechnology's future results, levels of activity, performance or achievements may not meet these expectations. The Company does
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
2. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
3. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
4. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
5. Genetic Engineering and Biotechnology News (GEN) Reports on Early ADMET Use
6. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
7. World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment
8. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
9. Genetic Engineering & Biotechnology News reports on growing use of cell-based assays
10. Genetic Engineering & Biotechnology News Reports on Growing Use of Cell-Based Assays
11. Genetic Engineering and Biotechnology News (GEN) Blog: International Students in the United States - A Diminishing Pool of Talent for Biotech?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... water with ultrasound and they,ll spin around their long ... knows exactly. But researchers at the National Institute of ... fast. At up to 150,000 revolutions per minute, these ... submerged in liquid ever reported. , The discovery of ... they could be used not only for moving around ...
(Date:7/22/2014)... 2014   BioTE Medical , a leading ... hormone pellets, today announced the addition of Dr. ... Dr. Rouzier is joining the BioTE Medical Advisory ... Dr. Rouzier was residency trained in Family Medicine ... board certified emergency physician still practicing at a ...
(Date:7/22/2014)... CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer ... cosmetics, and other markets, announced today that it has ... qualified private investors led by Novit L.P., an investment ... transaction involved the signing of a Securities Purchase Agreement ... Stock at a price per share of $1.00, resulting ...
(Date:7/22/2014)... Rice Lake, Wisconsin (PRWEB) July 22, 2014 ... will be in attendance at the 2014 NCSL ... Florida. Booth #423 will feature CONDEC pressure ... balance style weights, and the new, customized sets, ... years ago to promote cooperative efforts in solving ...
Breaking Biology Technology:NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2Dr. Neal Rouzier Joins BioTE Medical 2Dr. Neal Rouzier Joins BioTE Medical 3CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3Rice Lake Weighing Systems Showcases Metrology Solutions for the 2014 NCSL International Workshop & Symposium 2
... Company Posts Record Quarterly EPS of $0.58, 45% Above Prior Year, Based ... - Total Revenues Increase 21% to Establish Quarterly Record of $122.6 Million, ... 2008, Company Now Expects EPS of $1.72 to $1.76, Total Revenues of ... $450 to $455 Million -, ...
... commercial launch of first ... ... medicine,company, announced that Al Lucas has joined the Company as vice ... marketing,plan and initial launch strategy, building the sales force, and leading ...
... ,Monsanto Company (NYSE: MON ) and Mendel ... the development of Mendel,s BioEnergy,Seeds & Feedstocks business. ... from Monsanto,s industry-leading expertise in the testing,breeding, and ... worked together on the development of,biotechnology traits for ...
Cached Biology Technology:Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 2Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 3Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 4Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 5Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 6Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 7Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 8Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 9Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 10Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 11Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 12Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 13AssureRx Adds VP of Sales and Marketing 2Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration 2
(Date:7/22/2014)... most kids will hear that drinking milk helps make their bones ... these messages foster the idea that if something is good for ... in the Journal of Consumer Research , when children hear ... it. , "We predicted that when food is presented to children ... goal such as learning how to read or count, they would ...
(Date:7/22/2014)... July 22, 2014 BGI Tech Solutions ... the world,s largest genomics organization, announced today the ... sequencing service based on Complete Genomics, industry-leading platform. ... and SNP validation, and is available at reduced ... Genomics, highly regarded in the industry for providing ...
(Date:7/22/2014)... Nancy Buccola, MSN, APRN, PMHCNS-BC, CNE, Assistant Professor ... New Orleans School of Nursing, contributed samples used ... material associated with schizophrenia and also suggesting a ... The study, Biological insights from 108 schizophrenia-associated genetic ... Nature , available at http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13595.html., ...
Breaking Biology News(10 mins):BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2LSUHSC contributes to work identifying new DNA regions associated with schizophrenia 2
... appears to increase a person,s risk of developing late-onset Alzheimer,s ... will be presented as part of the late-breaking science program ... Toronto, April 10 17, 2010. The gene, abbreviated MTHFD1L, ... common variants in genes other than APOE been convincingly shown ...
... COLUMBUS, Ohio Scientists here are taking the trial and ... identify molecular structures that have the highest potential to serve ... designed to act on proteins that somehow malfunction in ways ... active ingredient in these medicines is typically a single molecule ...
... in French . , A new study, the ... techniques, to provide a more comprehensive and accurate picture of ... the April issue of neuroimaging journal Human Brain Mapping, ... and Hospital The Neuro, McGill University and the Universit ...
Cached Biology News:New gene associated with increased risk of Alzheimer's disease 2New drug design technique could dramatically speed discovery process 2New drug design technique could dramatically speed discovery process 3Dual approach gives a more accurate picture of the autistic brain 2Dual approach gives a more accurate picture of the autistic brain 3
1M stock solution (238mg/ml)...
...
Request Info...
... peptide derived from the C-terminal region catalytic ... C zeta isoform (PKCzeta). Specificity: Reacts ... Recognizes PKCzeta and PKMzeta (PKCzeta II) ... Reactivity: Mouse Rat (positive controls: mouse and ...
Biology Products: